Dr. Rachel N. Grisham presented findings at the 2026 Society of Gynecologic Oncology Annual Meeting showing that the ...

The big question in administration of bispecific antibodies these days is how quickly they can move to the outpatient setting—making them more convenient and cost-effective. Now, new study results for ...

CHRONOS is one of the largest real-world studies including refractory GI-aGvHD patients (n=59) treated with third-line best available treatments other than microbiome-based therapyResults from CHRONOS ...

Accused says he will cooperate ‘as long as he is granted probation rather than imprisonment’, but when told this cannot be ...

Detailed price information for Southern Cross Gold Consolidated Ltd (SXGC-T) from The Globe and Mail including charting and trades.

Outcomes remained poor overall, underscoring the need for clinical trials and novel therapies in this setting.

April 8, 2026) - Southern Cross Gold Consolidated Ltd (TSX: SXGC) (ASX: SX2) (OTCQX: SXGCF) (FSE: MV3) ("SXGC", "SX2" or the "Company") announces that the Company has filed and has obtained a receipt ...

AnaptysBio is splitting into a high-margin royalty company and a pipeline-focused biopharma, each with distinct valuation ...

Background Cardiac sarcoidosis (CS) creates complex treatment challenges, especially for patients who fail to respond to ...

Crispr Therapeutics AG looks set for 2026 revenue inflection as Casgevy ramps; strong efficacy, undervalued shares, robust ...

According to the latest study published by MarkNtel Advisors, the Global Silicon Carbide Market is projected to grow at a CAGR of around 27.12% during 2026?2032. The market expansion is primarily ...

Audited Annual Financial Statements Released in Australia and CanadaHighlightsTemas has secured multiple third-party RCL-based metallurgical technology services contracts during Q1 2026, as it rolls o ...